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ABSTRACT
Pemphigus vulgaris is an autoimmune disease characterized by the formation of suprabasal intra-epidermal blisters on 
the skin and mucosal surfaces. Infectious diseases are the main cause of death in patients with pemphigus due to the 
disrupture of the physiological skin barrier, immune dysregulation, and the use of immunosuppressive medications 
leaving the patient prone to acquire opportunistic infections. We report the case of a 67-year-old woman diagnosed with 
pemphigus vulgaris, who was irregularly taking prednisone and mycophenolate mofetil. She was hospitalized because 
of a 1-month history of watery diarrhea and oral ulcers. Unfortunately, the patient died suddenly on the ward. The 
autopsy revealed a bilateral saddle pulmonary embolism, Gram-positive cocci bronchopneumonia, and gastrointestinal 
cytomegalovirus infection, causing extensive gastrointestinal mucosal ulcers. 
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CASE REPORT
A 67-year-old woman sought the emergency 
department complaining of a 1-month history of 
watery diarrhea without mucus or blood, followed 
by the appearance of lesions in the oral cavity with 
odynophagia over the last 2 weeks. Despite 10 days of 
treatment with metronidazole in an outpatient clinic 
due to the presence of Blastocystis hominis in the stool 
examination, diarrhea persisted.
The patient had a medical history of pemphigus 
vulgaris and recurrent episodes of severe major 
depression. After histopathological confirmation of 
pemphigus vulgaris, which was initially diagnosed 
more than 10 years ago, the patient had been 
followed-up in the dermatologic clinic. Over the last 
7 years, she had been hospitalized several times to 
compensate the pemphigus and the depression. 
It should be added that she was used to inducing 
self-scarification of her skin lesions, and had significant 
problems with treatment compliance (i.e. she did not 
attend the appointments and refused to properly 
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treat her psychiatric condition). At the time of her last 
hospitalization, she was irregularly using prednisone 
60 mg/day and mycophenolate mofetil (MMF) 3 g/day.
In the emergency room, the physical examination 
revealed an emaciated patient with erosions covered by 
hematic crusts on the face, without signs of secondary 
infection. She also had an ulcer on the dorsal surface of 
the tongue and some erosions covered with a whitish 
exudate on the oral mucosa. Due to the diagnostic 
hypothesis of oral and esophageal candidiasis, the 
patient was treated with fluconazole with partial relief 
of the odynophagia. Abnormal laboratory findings 
included normocytic and normochromic anemia, 
lymphopenia (530 cells/mm3 (reference value [RV]: 
900-3400 cells/mm3), mildly elevated pancreatic 
enzymes (amylase and lipase), and leukocyturia. 
Based on the urinalysis result, ciprofloxacin was 
prescribed; and a urine culture further identified 
negative-coagulase Staphylococcus sp. The chest x-ray 
was normal.
On the fourth day of hospitalization, an upper 
digestive endoscopy evidenced extensive erosive 
esophagitis, and gastric antral erosions; biopsies were 
performed. The pathological report was released post 
mortem. After 6 days of hospitalization, the patient 
had a sudden cardiac arrest in pulseless electrical 
activity, and our rapid response team (“blue code”) 
attempted resuscitation. Unfortunately, the patient did 
not respond to the standard resuscitation maneuvers. 
An autopsy was performed with the consent of her 
relatives.
AUTOPSY FINDINGS
The corpse weighed 42.0 kg and measured 
1.60 m (body mass index = 16.4 kg/m2). The ectoscopy 
revealed an emaciated female corpse. Erosions with 
fibrin-hematic crusts were observed bilaterally on the 
malar skin (Figure 1).
At the opening of the cavities, no abnormalities 
were found. There was an organized thrombus in the 
right atrium extending to the tricuspid valve (Figure 2A). 
The right lung weighed 744.0 g (mean RV = 450 g) and 
the left weighed 686.0 g (mRV = 375 g). Both lungs had 
a massive saddle pulmonary embolism, which extended 
to the peripheral branches. The cut surface of the lungs 
showed marked congestion, draining a foamy, pinkish 
liquid when compressed, with firm consistency in the 
basal regions (Figure 2B). At microscopy, the lung 
parenchyma had extensive areas of bronchopneumonia 
caused by Gram-positive cocci associated with diffuse 
alveolar damage (congestion, alveolar edema and 
hemorrhage, and hyaline membranes) and numerous 
arterial thrombi (Figure 2C, D).
An extensive ulcer, measuring 2.5 cm in diameter, 
was found on the tongue’s dorsal surface (Figure 3A), 
which histopathologically corresponded to an ischemic 
ulcer with ongoing regeneration, neutrophilic 
inflammatory infiltrate, granulation tissue, and 
reepithelization (Figure 3B). Within the surrounding 
areas of the ulcer there were multiple inflammatory, 
stromal, and endothelial cells presenting cytomegaly 
and intranuclear eosinophilic inclusion, surrounded by a 
clear halo, which was consistent with cytomegalovirus 
infection (Figure 3B).
The esophagus presented several small erosions, 
and the stomach had ulcers with punctuated 
hemorrhages measuring less than 1.0 cm in diameter. 
The colonic mucosa was covered by multiple fibrinous 
plates measuring from 0.7 cm to 2.0 cm in diameter, 
intermingled with scattered ulcerations measuring on 
the average of 0.5 cm in diameter, from the cecum 
to the descendent colon (Figure 3C). The microscopic 
examination of the gastrointestinal ulcers showed 
similar findings as the tongue: mucosal ulcers with 
neutrophilic inflammatory infiltrate, granulation tissue, 
and endothelial cytomegalic inclusion, stromal, and 
inflammatory cells. Immunohistochemistry (mouse 
anti-cytomegalovirus [CMV] cocktail of DDG9 and 
Figure 1. Pemphigus vulgaris facial lesions: erosions 
with fibrin-hematic crusts on the malar region.
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CCH2, Diagnostic BioSystems, Pleasanton, CA, USA) 
was performed and all gastrointestinal lesions stained 
positively for cytomegalovirus in the nuclear inclusions 
of the cytomegalic cells (Figure 3D).
Additional findings of the autopsy included 
multiple organ damage due to septic shock, such as 
discrete lymphomononuclear myocarditis, nutmeg 
liver, splenitis, and acute tubular necrosis.
DISCUSSION
Taken together, the clinical and autopsy findings 
described in the present report can be interpreted as 
a patient with pemphigus vulgaris (the underlying 
cause of death) and recurrent major depression, under 
chronic immunosuppression secondary to prednisone 
and MMF. Tapering off the immunosuppressive 
therapy was not possible as the patient remained with 
active pemphigus vulgaris lesions due to treatment 
non-compliance. As a consequence, she acquired two 
infections: (i) cytomegalovirus infection reactivation, 
producing diffuse lesions in the gastrointestinal tract, 
with prolonged symptomatic diarrhea and odynophagia 
before her death; and (ii) nosocomial pneumonia 
due to Gram-positive cocci (an autopsy finding, 
not clinically suspected). Both infections certainly 
induced to prothrombotic state, leading to a massive 
pulmonary embolism, which was the immediate 
cause of her death.1-3 The malnutrition observed at 
her physical exam was probably synergistic with the 
drug-induced immunosuppression, corroborated by 
the anorexia caused by reduced food intake due to 
Figure 2. A - Gross examination of the heart showing an organized thrombus in the right atrium (arrow); B - Saddle 
pulmonary thromboembolism in the right lung (arrow); C - Micrography of the lungs showing suppurative 
bronchopneumonia (arrow) associated with colonies of cocci (arrowhead) (H&E, 55X); D - Gram-positive cocci in 
the areas of suppurative pneumonia (arrows) (Brown-Brenn, 400X).
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painful oral lesions,4 and lymphopenia, which was 
evidenced in her first complete blood count at this 
final hospitalization.5-7
Pemphigus vulgaris is an autoimmune disease 
characterized by the formation of suprabasal 
intra-epidermal blisters on the skin and mucosal 
surfaces, due to the destruction of the epithelial 
desmosomes by autoantibodies.8 Until the 1950s, the 
5-year mortality related to pemphigus vulgaris was 
100%.9 Mortality decreased to 25-45% with the use 
of systemic corticosteroids but adverse effects, such 
as diabetes, osteoporosis, dyslipidemia, and cataracts, 
led to the introduction of immunosuppressants as 
steroid-sparing agents.10,11 Death rates improved to 
5-10% with adjuvant immunosuppression, but the risk 
of opportunistic infections increased.11,12
Infectious diseases are the main cause of death in 
patients with pemphigus.13-15 Few studies are published 
on the autopsies of patients with autoimmune bullous 
disorders concerning the pathology of their death. 
To the best of our knowledge, in 1984 Aki et al.16 
performed the study with the largest number of 
patients including 18 autopsied cases. Among them, 
10 had pemphigus vulgaris and 8 had pemphigus 
foliaceus. In the group with pemphigus vulgaris, nine 
deaths were attributed to infectious diseases related 
to immunosuppressive therapy, such as disseminated 
strongyloidiasis (two cases), military tuberculosis 
Figure 3. A - Gross examination of the tongue depicting an ulcer on the dorsum (arrow); B - Micrography of the 
tongue showing mucosal ulcer with endothelial cells exhibiting cytomegalic cytopathic effect (arrow and inset) 
(H&E, 300X); C - Macroscopic examination of the colonic mucosa exhibiting small ulcers (arrows); D - Micrography 
of the colon showing a positive immunohistochemistry reaction for cytomegalovirus (CMV) antigens, detecting 
cytomegalic endothelial (arrow) and inflammatory (arrow head) cells in a colonic ulcer, with nuclear staining (mouse 
anti-CMV cocktail of DDG9 and CCH2, Diagnostic BioSystems, 400X).
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(two cases), pneumonia (three cases), sepsis related 
to Gram-positive cocci, and colitis (one case).16 Other 
isolated autopsy case reports showed bronchiolitis 
obliterans17 and lymphomatoid granulomatosis18 as 
causes of death in patients with pemphigus vulgaris.
CMV is a common human pathogen, and a 
member of the Herpesviridae family. Estimates of the 
worldwide prevalence of CMV infection range from 
40% to 100%, with greater indexes in underdeveloped 
or developing countries due to higher population 
density.19 CMV transmission occurs through “close 
contact”, saliva, urine, sexual contact, and vertical 
transmission (the latter usually during early childhood). 
A Brazilian study conducted in Caieiras, a city in the 
northern area of the São Paulo State, showed that 
90% of the infants had maternal antibodies against 
CMV.20 The immunocompetent hosts most commonly 
have an asymptomatic infection, and some develop 
a mononucleosis-like syndrome. The congenital 
cytomegalovirus infection occurs when a pregnant 
woman transmits the virus vertically to the fetus. After 
an acute phase, the CMV can establish a latent infection 
into the host cells that can reactivate under systemic 
immunosuppression (AIDS, post-transplantation, 
post-chemotherapy, and the use of steroids and other 
immunosuppressive drugs).21 The immunocompromised 
host with CMV disease can develop lesions in almost all 
organ systems, but mainly in the gastrointestinal tract 
(esophagitis, gastritis, colitis, ulcers, and perforations), 
the lungs (pneumonitis), the liver (hepatitis), the eyes 
(retinitis) and the nervous system (encephalitis and 
myelitis). Gastrointestinal CMV disease, with superficial 
mucosal lesions, can be diagnosed when the CMV 
nuclear inclusions are only seen in the epithelial cells 
(owl’s eye aspect) in a tissue sample. The invasive 
and systemic CMV disease is evidenced when the 
pathologist detects cytomegalic endothelial cells–with 
the typical nuclear inclusion–obliterating the vascular 
lumen, causing ischemic necrosis and ulceration of the 
gastrointestinal mucosa. Epithelial and stromal cells are 
also affected.22,23 The clinical manifestations include 
fever, malaise, weight loss, abdominal pain, diarrhea 
(watery or bloody), dysphagia, odynophagia, anemia, 
leucopenia, and viremia.24
CMV infection has been described among 
patients with pemphigus vulgaris under steroid therapy 
associated or not with azathioprine or rituximab, 
causing asymptomatic erythematous gastritis,25 gastric 
ulcers,22 or skin lesions.23 In a prospective cohort study 
of patients with pemphigus vulgaris, Leshem et al.12 
found an incidence of 8.1% (14/172 patients) of 
opportunistic infections (OI) within the first year of 
follow-up. Two patients had fatal CMV disease: one 
had cutaneous and lung CMV infections, and the other 
presented systemic CMV. Advanced age and possibly 
diabetes were associated with an increased risk for OI 
among patients with pemphigus in this study.12
It should be emphasized that autoimmune bullous 
disorders can be superinfected or colonized by the 
herpes simplex virus (HSV).26 Besides HSV, which 
is the most common virus infection described,26-30 
herpes virus 8 (HHV-8) may cause localized lesions 
of Kaposi sarcoma in areas previously treated with 
corticosteroid infiltrations,31 multifocal lesions,32 or 
skin colonization with uncertain clinical significance.33 
CMV is described as causing skin superinfection 
or disseminated disease in some reports.12,23,34 
The Herpesviridae virus superinfection must be 
suspected when there are bullous or ulcerative 
lesions refractory to immunosuppressive treatment. 
Diagnosis confirmation relies on histopathological 
or immunohistochemical analysis of skin samples, 
and through a polymerase chain reaction to detect 
CMV-DNA in blood samples (viremia).12,30,35,36 Our case 
illustrates how an infection can be detrimental to a 
patient with autoimmune bullous disorder. Despite 
proper diagnostic and therapeutic measures towards 
the patient’s complaints and clinical conditions, she 
had a fatal outcome due to a saddle pulmonary 
thromboembolism. Epidemiological data provide 
evidence of the association between acute infections 
and thromboembolic events, including deep vein 
thrombosis and pulmonary embolism. The risk of 
thrombotic events increases more than 2-fold within a 
period of 2 weeks to 3 months after either community 
or nosocomial infections of the respiratory and urinary 
tracts, blood, abdomen, skin, or soft tissues, and Gram-
positive bacterial infections.1,2 An autopsy-based study 
conducted at King’s College Hospital (London, UK) 
found that among 110 patients with fatal pulmonary 
embolism associated with well-defined clinical 
conditions, 26 (23.6%) had infections–predominantly 
in the respiratory tract–during the 6 weeks prior to 
death.3 The reasons why an infection predisposes to a 
prothrombotic state are still not fully understood, but 
endothelial damage by virus or bacterial infections, 
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dehydration, and white-cell activation have been 
implicated.37,38 In the current case, CMV gastrointestinal 
infection and nosocomial pneumonia were the 
determinants for the patient’s death. The suppurative 
pneumonia identified at the autopsy was probably not 
clinically diagnosed because the patient was receiving 
immunosuppressive drugs, and oral ciprofloxacin for 
urinary infection and diarrhea, which could mask the 
signs and symptoms of the respiratory infection.
Patients with bullous autoimmune disorders 
exhibit a higher infectious risk related to the 
disrupture of the physiological skin barrier, leading 
to colonization and infection with bacteria and other 
microorganisms, immune dysregulation, and the use 
of immunosuppressive medications.15,39 Infections 
are one of the main adverse effects of steroids, as 
they downregulate the innate and cell-mediated 
adaptive immune responses against intracellular 
microorganisms.5 MMF inhibits the purine nucleotide 
synthesis, an essential pathway to lymphocytes 
proliferation. Therapeutic regimens, including MMF, 
are associated with an increased likelihood of CMV 
disease among kidney transplant recipients.6
As a secondary preventive measure to infections, 
physicians must be aware of the signs and symptoms 
of infection, especially OI, caused by a myriad of agents 
(such as CMV), to provide early diagnosis and adequate 
treatment to the patients under immunosuppressive 
therapy.
A recent evidence-based guideline on the 
screening for infectious diseases in patients with 
autoimmune bullous dermatoses, recommends 
testing patients for Mycobacterium tuberculosis, and 
hepatitis B and C viruses, before prescribing rituximab 
treatment.14 On the other hand, doctors must educate 
their patients to avoid colonization and infection of 
their skin (proper hand washing, nail cleaning, and 
avoiding any physical contact with other patients) 
and recognize early signs and symptoms of infection 
to seek health assistance for rapid diagnosis and 
treatment.36 In addition, patient compliance to the 
medical prescription and follow-up appointments must 
be actively persuaded to prevent misuse of medications 
and consequent prolonged immunosuppression, which 
can lead to a fatal outcome, such as the one we have 
described here.
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